Severe myoclonic epilepsy in infancy: Toward an optimal treatment

Journal of Child Neurology

Volumn 19, Issue 7, 2004, Pages 516-521

  Ceulemans, Berten ^a,b,c   Boel, Marc ^a,e   Claes, Lieve ^c   Dom, Lina ^f   Willekens, Herman ^g   Thiry, Paul ^h   Lagae, Lieven ^a,e   Eiken, Drie ^d  

^a Epilepsy Center for Children/Youth   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^f Queen Paola Children's Hospital   (Belgium)

^g AZ St Lucas   (Belgium)

^h St Oda Institute   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORAL HYDRATE; CLOBAZAM; CLONAZEPAM; DIAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; SODIUM CHANNEL; STIRIPENTOL; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ALPHA CHAIN; ARTICLE; CAREGIVER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPTIC STATE; FACE DISORDER; FEMALE; FEVER; GENE MUTATION; GINGIVA HYPERPLASIA; HEALTH EDUCATION; HUMAN; HYPERTHERMIA; INFANT; INFANT DISEASE; INTERMETHOD COMPARISON; MAINTENANCE THERAPY; MALE; MEDICAL LITERATURE; MENTAL STRESS; MYOCLONUS EPILEPSY; PARENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; SALIVATION DISORDER; SOMNOLENCE; TREATMENT PLANNING;

EID: 8344237408     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738040190070701     Document Type: Article

References (30)

1. Dravet C: Les épilepsies graves de l'enfant. Vie Méd 1978;8:543-548.
2. Dravet C, Bureau M, Roger J: Severe myoclonic epilepsy in infants, in Roger J, Dravet C, Bureau M, et al (eds): Epileptic Syndromes in Infancy, Childhood and Adolescence. London, John Libbey, 1985, 58-67.
3. Commission on Classification and Terminology of the ILAE. Epilepsia 1989;22:489-501.
4. Engel J: ILAE Commission report. Epilepsia 2001;42:796-803.
5. Hurst DL Epidemiology of severe myoclonic epilepsy of infancy. Epilepsia 1990;31:397-400.
6. Dravet C, Bureau M, Oguni H, et al: Severe myoclonic epilepsy in infancy (Dravet syndrome), in Roger J, Bureau M, Dravet C, et al (eds): Epileptic Syndromes in Infancy, Childhood and Adolescence, 3rd ed, Eastligh, John Libbey, 2002, 81-103.
7. Claes L, Del-Favero J, Ceulemans B, et al: De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-1332.
8. Claes L, Ceulemans B, Audenaert D, et al: De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat 2003;21:615-621.
9. Ceulemans B, Claes L, Lagae L, De Jonghe P: Clinical correlations of mutations in the SCN1A gene: From febrile seizures tot SMEI. Pediatr Neurol 2004;30:236-243.
10. Horn CS, Ater SB, Hurst DL: Carbamazepine-exacerbated epilepsy in children and adolescents. Pediatr Neurol 1986;2:340-345.
11. Wakai S, Ito N, Sueoka H, et al: Severe myoclonic epilepsy in infancy and carbamazepine. Eur J Pediatr 1996;155:724.
12. Guerrini R, Dravet C, Genton P, et al: Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 1998;39:508-512.
13. Saito Y, Oguni H, Awaya Y, et al: Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy. Neuropediatrics 2001;32:231-235.
14. Perez J, Chiron C, Musial C, et al: Stiripentol: Efficacy and tolerability in children with epilepsy. Epilepsia 1999;40:1618-1626.
15. Chiron C, Marchand MC, Tran A, et al: Stiripentol in severe myoclonic epilepsy in infancy: A randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet 2000;356:1638-1642.
16. Guerrini R, Tonnelier S, d'Athis P, et al: Stiripentol in severe myoclonic epilepsy in infancy (SMEI): A placebo-controlled Italian trial, abstract. Epilepsia 2002;43(Suppl 8):155.
17. Thanh TN, Chiron C, Dellatolas G, et al: Long-term efficacy and tolerance of stiripentol in severe myoclonic epilepsy of infancy (Dravet syndrome). Arch Pediatr 2002;9:1120-1127.
18. Kanazawa O: Can early zonisamide medication improve the prognosis in the core and peripheral types of severe myoclonic epilepsy in infants? Brain Dev 1999;21:503.
19. Kanazawa O: Refractory grand mal seizures with onset during infancy including severe myoclonic epilepsy in infancy. Brain Dev 2001;23:749-756.
20. Nieto-Barrera M, Candau R, Nieto-Jimenez M, et al: Topiramate in the treatment of severe myoclonic epilepsy in infancy. Seizure 2000;9:590-594.
21. Coppola G, Capovilla G, Montagnini A, et al: Topiramate as addon drug in severe myoclonic epilepsy in infancy: An Italian multicenter open trial. Epilepsy Res 2002;49:45-48.
22. Villeneuve N, Portilla P, Ferrari AR, et al: Topiramate (TPM) in severe myoclonic epilepsy in infancy (SMEI): Study of 27 patients, abstract. Epilepsia 2002;43(Suppl 8): 155.
23. Burkart P, Schneble H, Ziegler G: Topiramate in severe myoclonic/convulsive epilepsy of infancy. Epilepsia 1999;40(Suppl 2)179.
24. Yeung S, Ferrie CD, Murdoch-Eaton DG, Livingston JH: Topiramate for drug-resistant epilepsies. Eur J Paediatr Neurol 2000; 4:31-33.
25. Wallace SJ: Newer anti-epileptic drugs: Advantages and disadvantages. Brain Dev 2001;23:277-283.
26. Campos Castello J: Therapeutic strategy in severe encephalopathies. Rev Neurol 2001;32:860-866.
27. Genton P: When antiepileptic drugs aggravate epilepsy. Brain Dev 2000;22:75-80.
28. Shields WD: Catastrophic epilepsy in childhood. Epilepsia 2000;41(Suppl 2):S2-S6.
29. Lossin C, Wang DW, Rhodes TH, et al: Molecular basis of an inherited epilepsy. Neuron 2002;34:877-884.
30. Fişgin T, Gurer Y, Tezic T, et al: Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: Prospective randomized study. J Child Neurol 2002;17:123-126.